Three patients were lost to follow-up for different reasons One

Three patients were lost to follow-up for different reasons. One patient was not satisfied with the treatment results and chose to discontinue in the study, another

patient had difficulty attending the treatment centre because of long distance travel and chose to withdraw from the study and the buy NVP-BKM120 third patient was lost to follow up as a result of social problems of a personal nature. There was an increase in patients’ mean weight over the 3-year period, with two patients having a >10% weight gain at 36 months compared with their baseline weight. Although weight gain can be a potential confounder for our results, no association between weight gain and atrophy reversal was found in an earlier study where 40 HIV-positive patients with lipoatrophy were followed up for 44 months [5]. In addition, the same study found that facial atrophy was less reversible than fat atrophy of the extremities [5]. Treatment with large particle hyaluronic acid was well tolerated in this study. Adverse events included swelling and tenderness selleck kinase inhibitor in the week after treatment, and skin indurations present at the 6-week post-treatment consultation. Skin indurations were typically non-visible, small, mild and disappeared over time. None of the skin indurations was clinically inflammatory in nature. The incidence of skin induration per treatment session was 23% at baseline, 21% at the 12-month visit and 16% at the 24-month visit. A 12 month

follow-up study of Restylane SubQ treatment in non HIV-positive patients [13] reported a similar adverse event profile to our study, with most adverse events being mild and skin indurations reported in 26% of patients. In that study,

skin induration was frequently delayed and of mild intensity, persisting for 4 months on average, and implantation problems, such as mobility or extrusion of the implant, were reported in 19% of patients [13]. We did not see any such implantation problems in our study. In our study, the decrease seen in the incidence of skin indurations per treatment session could be explained by an improved injection technique, as more experience was gained with the amount of product used and the location of injection. A decrease in the high PIK3C2G incidence of subcutaneous papule formation associated with polylactic acid injection, 52% to 13% of patients, has been attributed to more experience with the product [18]. A recent report cited the rate of subcutaneous papule formation in studies of polylactic acid treatment to range from 5% to 44% [10]. A 64-week follow-up study of Restylane SubQ treatment in non-HIV-positive patients [19] reported a very low incidence of skin induration (<1%) which the investigators attributed to following a consistent submuscular injection technique. The producers of Restylane SubQ have advised against injecting more than 2 mL per treatment because of the risk of skin induration [14].

, 2001) All components of both systems were heterologously produ

, 2001). All components of both systems were heterologously produced in Escherichia coli (Schilhabel et al., 2009). Both MT I are zinc-containing enzymes (Schilhabel et al., 2009). Zinc may have structural or catalytic functions in proteins (Vallee & Auld, 1990a, b). The metal is generally bound to the side chains of histidine, cysteine, aspartate or glutamate (Vallee & Auld,

1990a). In most cases, zinc is bound to three amino acid side chains and one water molecule when the metal has a catalytic function in enzymes (Auld, 2001). These zinc-binding motifs usually exhibit common characteristics with regard to the distances between the zinc-binding amino acids in the primary structure of the proteins (Auld, 2001). Two of these amino acids are separated by a short distance of one to three amino acids; the third ligand

is located at a distance of 20–120 amino acids to the other ligands PI3K inhibitor (Vallee & Auld, 1990a). Exceptions to this rule are the cofactor-dependent alcohol dehydrogenase (Vallee & Auld, 1990a) and the cobalamin-dependent methanol methyltransferase of Methanosarcina barkeri (Hagemeier et al., 2006). In this study, we report on the identification of the zinc-binding motifs of MT Ivan of the vanillate-O-demethylase and MT Iver of the veratrol-O-demethylase of A. dehalogenans using site-directed mutagenesis. Acetobacterium dehalogenans was cultivated anaerobically as described Pictilisib earlier (Traunecker et al., 1991). Syringate (20 mM) or fructose (20 mM) was used as a growth substrate. The production of the recombinant proteins and the purification of the methyltransferases and of CP were performed as described earlier (Schilhabel et al., 2009). For the activation reaction, crude extracts of E. coli containing the recombinant AE were used. These crude extracts did not exhibit methyltransferase Abiraterone chemical structure activity. Cells of A. dehalogenans (0.2 g wet weight) were

suspended in 1 mL 10 mM Tris-HCl, pH 8.0, containing 10 mM EDTA. The genomic DNA was isolated according to Bollet et al. (1991). After incubation with 0.01% RNase (w/v) for 15 min at 37 °C, the DNA was stored at 4 °C. Expression cassettes of the mutated genes of MT Ivan and MT Iver (GenBank accession no. AF087018 and AY318856) as fusion proteins with a C-terminal Strep-tag and with restriction sites for the cloning in pET11a (Agilent Technologies, Böblingen, Germany) were constructed from PCR products. Point mutations of both enzymes were generated using overlap extension PCR essentially using the method described by An et al. (2005). The mutations were inserted using multistep PCR. In the first PCR step, two fragments were amplified: one by the combination of primer 1 (MT Ivan) or 3 (MT Iver) (Table 1) with the mutated reverse primer and the other fragment by the combination of the mutated forward primer with primer 2 (MT Ivan) or 4 (MT Iver) (Table 1).

g 10 °C or lower) This study was supported by a grant from the

g. 10 °C or lower). This study was supported by a grant from the MEST (Ministry of Education, Science and Technology)/NRF to the Environmental Biotechnology National Core Research Center (Grant #20090091 489). This study was also supported by Selleck EPZ5676 an NRF grant funded by the MEST (Grant #2009-0070747). M.H.C was supported by EBNCRC. J.X and X.P.Z were supported by graduate scholarships through the BK21 program funded by the MEST, Korea. The authors express sincere thanks to Prof. Jun Zhu at the Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, for the kind donation of plasmids and his valuable

suggestions. “
“Copper (Cu)-based biocides are important chemical controls for both fungal and bacterial

diseases in crop fields. Here, we showed that Cu ions at a concentration of 100 μM enhanced t-butyl hydroperoxide (tBOOH) and hydrogen peroxide (H2O2) killing of Xanthomonas campestris pv. campestris through different mechanisms. The addition of an antilipid peroxidation agent (α-tocopherol) and hydroxyl radical scavengers (glycerol and dimethyl sulphoxide) partially protected the bacteria from the Cu-enhanced tBOOH and H2O2 killing, respectively. Inactivation of the alkyl hydroperoxide reductase gene rendered the find more mutant vulnerable to lethal doses of copper sulphate, which could be alleviated by the addition of an H2O2 scavenger (pyruvate) and α-tocopherol. Taken together, the data suggest that Cu ions influence the killing effect Ribonucleotide reductase of tBOOH through the stimulation of lipid peroxidation, while hydroxyl radical production is the underlying mechanism responsible for the Cu-ion-enhanced H2O2 killing effects. Xanthomonas campestris is an important

phytopathogen that causes damaging diseases in economically important crops worldwide. During plant–microorganism interactions, the rapid production and accumulation of reactive oxygen species (ROS) is an initial defence response against the infecting microorganisms (Levine et al., 1994). Plant lipoxygenases that catalyse the formation of fatty acid hydroperoxide have been shown to be induced by microbial invasion and are involved in plant–microbial defence responses (Croft et al., 1993; Kolomiets et al., 2000; Jalloul et al., 2002). These ROS are highly toxic and exert detrimental effects on the invading microorganisms through their ability to stimulate lipid peroxidation and protein and DNA damage that eventually lead to cell death (Farr & Kogoma, 1991). Copper (Cu) is required as a cofactor for a variety of enzymes, such as terminal oxidases, monooxygenases, and dioxygenases. An excess of Cu in aerobic cells generates ROS through a Fenton-like reaction, in which Cu (I) ions react with hydrogen peroxide (H2O2) to form hydroxyl radicals (Gunther et al., 1995). Nonetheless, the precise mechanisms by which Cu ions exert lethal effects on bacterial cells remain ambiguous.

Although distance from clinic was not directly related to non-adh

Although distance from clinic was not directly related to non-adherence, patients living in a rural setting may not have access to these services, thus the role of the community pharmacist is highly pertinent Community Pharmacy has a key role to play in addressing these barriers when conducting MURs and prompting patients to consider their eye-medication when taking a drug history. The effective

management of glaucoma is dependent on good adherence to eye drop medication, since there is a direct link between poor control of intraocular pressure and deterioration of eye sight. Non-adherence to eye medication is estimated to be around 25% (1) which is similar to figures reported for other chronic conditions. Reasons for poor adherence to medicines

are well recognised as multi-factorial, involving practical and perceptual issues. Living in a rural area may also pose selleck kinase inhibitor additional practical barriers, but it is not clear how this TAM Receptor inhibitor influences patient adherence to treatment. The aim of the study was to identify the level of non-adherence and factors that influence adherence to eye-medication in a rural setting. One-to-one interviews were carried out with seven healthcare professionals involved in the prescribing and supply process and three patients to identify the practical barriers to adherence to eye-medication. Thematic analysis of qualitative data were not included in reported results but informed the design of a questionnaire which quantified the extent to which patients experienced these issues. The setting was an eye-clinic in a rural area of Mid-West Wales. Following Health Board Ethics Committee approval, patients

were invited to complete a researcher-administered study questionnaire while waiting for their out-patient appointment. This was divided into five sections: a) patient demographic details including distance from the clinic, b) self-reported adherence, c) level of information provided Abiraterone about administration d) views about the eye drop medication (based on a previously validated questionnaire2) and e) supply / access to medication. Of the 53 patients approached to take part in the study, 51 (96%) completed the study questionnaire. Most (80%) patients reported a good level of adherence (i.e. below a mid-point scale score of 21; 7 to 35 with a high score indicating low adherence) and this was not found to be related to distance from the clinic. A relationship was found between patients who had not been assessed for ability to administer their eye-drops and poor adherence (rho = −0.324, n = 51, p < 0.02). Similarly patients who identified barriers such as dexterity and ability to read labels, demonstrated a lower adherence (rho = 0.756, n = 51, p < 0.05).

However, it is not precisely known which species of microorganism

However, it is not precisely known which species of microorganisms play the principal part in these beneficial properties. Some major find more health benefits of probiotics and their proposed mechanisms are illustrated in Table 1. Several probiotic bacteria have been introduced in the market, and the range of products in which probiotic bacteria are added is increasing (Table 2).

Some of the major health attributes of probiotics are discussed in the following sections. Resistance to enteric pathogens Antagonism activity Adjuvant effect increasing antibody production Systemic immune effect Colonization resistance Limiting access of enteric pathogens (pH, bacteriocins/defensins, antimicrobial peptides, lactic acid production, and toxic oxygen metabolites) Aid in lactose digestion Bacterial lactase acts on lactose in the small intestine Small bowel FG4592 bacterial overgrowth Lactobacilli influence the activity of overgrowth flora, decreasing toxic metabolite production Normalization of a small bowel microbial community Antibacterial characteristics Immune system modulation Strengthening of nonspecific and antigen-specific

defense against infection and tumors Adjuvant effect in antigen-specific immune responses Regulating/influencing Th1/Th2 cells, production of anti-inflammatory cytokines Decreased release of toxic N-metabolites Anticolon cancer effect Antimutagenic activity Detoxification of carcinogenic metabolites Alteration in pro-cancerous enzymatic activity of colonic microorganisms Stimulation

of immune function Influence on bile salt concentration Decreased detoxification/excretion of toxic microbial metabolites Increased bifidobacterial cell counts and shift from a preferable protein- to carbohydrate-metabolizing microbial community, less toxic and for putrefactive metabolites, improvements of hepatic encephalopathy after the administration of bifidobacteria and lactulose Prevention of antigen translocation into blood stream Prevent excessive immunologic Baf-A1 in vivo responses to increased amount of antigen stimulation of the gut Blood lipids, heart disease Assimilation of cholesterol by bacterial cell Alteration in the activity of BSH enzyme Antioxidative effect Bacterial peptidase action on milk protein results in antihypertensive tripeptides Cell wall components act as ACE inhibitors Adhesion to urinary and vaginal tract cells Competitive exclusion Inhibitor production (H2O2, biosurfactants) Infection caused by Helicobacter pylori Competitive colonization Inhibition of growth and adhesion to mucosal cells, decrease in gastric H.

When endothelial cells were infected with S suis S735 serotype 2

When endothelial cells were infected with S. suis S735 serotype 2, only isolated bacteria and small chains were visualized (Fig. 1b). Additional serotype 2 strains (90-1330, 99-1539B, 89-4223, 89-999, 31533)

were also found to adhere markedly less to endothelial cells when compared with nontypeable isolates (data not shown). Streptococcus suis strains were analysed using transmission electron microscopy and ruthenium red staining for the presence of a polysaccharide capsule. selleck inhibitor Figure 2c–j shows that nontypeable S. suis 1079277, 1078212, 1185293, and 1148795 did not express a dense capsule. The three other nontypeable strains of S. suis (1097925, 1077009, and 1079506) were also devoid of capsule (data not shown). By contrast, S. suis S735 (Fig. 2a and b) as well as two other serotype 2 strains tested (data not shown) possessed a thick and dense capsule. We then evaluated whether capsule expression alters the cell surface hydrophobicity

of S. suis. As shown in Table 2, nontypeable S. suis 1079277, 1097925, 1078212, this website 1185293, 1148795, 1077009, and 1079506 showed a high percentage of cell surface hydrophobicity (≥52%). On the contrary, the hydrophobicity of all S. suis serotype 2 strains was <29%. In view of the above results, we investigated the capacity of autoaggregation of S. suis strains. Table 2 shows that nontypeable isolates were able to autoaggregate to various extents, while the serotype 2 strains could not. All the tested S. suis strains possessed cell-associated DPP IV activity. However, only six strains of S. suis ADP ribosylation factor (S735, 1078212, 1079277, 1097925, 1185293, and 1148795) showed subtilisin-like protease activity after 4 h of incubation. Extending the incubation to 24 h did not modify the result. Finally, we compared biofilm formation by nontypeable and serotype 2 strains of S. suis. Figure 3 shows that nontypeable isolates had the capacity to form a dense biofilm into wells of the polystyrene plate while serotype 2 strains had

no such property. Only slight variations were observed regarding the growth capacity of all S. suis strains (data not shown). Streptococcus suis is a Gram-positive cocci that possesses cell wall antigenic determinants related to Lancefield group D (Facklam, 2002). Based on the capsular composition, currently, there are 35 serotypes described for S. suis species (Gottschalk & Segura, 2000; Messier et al., 2008). Serotyping is an important step in the routine diagnostic procedure for S. suis infections. Different procedures have been described, but most laboratories use the coagglutination technique (Higgins & Gottschalk, 2001; Costa et al., 2005). Although the incidence of nontypeable isolates is in general low, their isolation is reported in the literature (Higgins & Gottschalk, 2000; Wei et al., 2009). Because very few data are available regarding the properties of nontypeable pathogenic S.

, 2007) In C rodentium, an AraC-like regulatory protein, RegA,

, 2007). In C. rodentium, an AraC-like regulatory protein, RegA, has been shown to regulate virulence by stimulating transcription of the grlRA in the presence of gut signals, such as bicarbonate ions (Hart et al., 2008; Yang et al., 2008, 2009; Tauschek et al., 2010). All these findings indicate that the expression of LEE genes is finely regulated by the combined action of different global regulators. Here, we report that in C. rodentium, the global regulator Lrp negatively regulates genes carried by the LEE island. Lrp acts directly on LEE1 expression

and indirectly, most likely through ler, on other LEE genes. Our results introduce an additional factor to the plethora of transcriptional regulators so far shown to be involved in the expression of LEE genes (Mellies et al., 2007), thus providing a further step toward a full understanding Ganetespib of the molecular mechanism of C. rodentium pathogenicity. Citrobacter rodentium ATCC51459 was used as the parental strain to generate the congenic recombinant strains EM2, carrying a lrp deletion as described previously (Cordone et al., Fluorouracil mouse 2005). Escherichia coli K12 DH5a [supE44 DlacU169 (f80DlacZM15) hsdR17 recA1] (Sambrook & Russell, 2001) was used for all cloning experiments, while E. coli K12 BL21 (DE3) was used for Lrp over-expression. Bacterial cultures were diluted from an overnight culture to OD600 nm 0.1 in rich

medium (LB), grown in shaking condition at 37 °C up to early stationary

phase. Optical density at 600 nm was followed during growth and entry into stationary phase determined between 1.0 and 1.2 OD600 nm. Cells were collected at 1.5 OD600 nm by centrifugation and kept at −80 °C until RNA extraction. Plasmid and chromosomal DNA preparation, restriction digestion, ligation, bacterial transformation, agarose gel electrophoresis, and SDS–PAGE were performed as described (Sambrook & Russell, 2001). Plasmid pAC1 was obtained by cloning a 495-bp product resulted by PCR amplification performed with C. rodentium chromosomal DNA as template and oligonucleotides Lrp-s and Lrp-a (Table 1) as primers into a pGEMT-easy (Promega) vector. The PCR product, containing the coding region of the C. rodentium Amino acid lrp gene, was excised by EcoRI digestion of plasmid pAC1 and transferred into the pRseT-B (Invitrogen) vector downstream and in frame with a sequence that encodes a histidine hexapeptide tag, yielding plasmid pAC100. The resulting plasmid was used to transform E. coli BL21(DE3), generating strain AC101. Plasmid pAC45 was obtained by cloning 530-bp fragment containing the promoter region of the C. rodentium lrp gene into a pGEMT-easy (Promega) vector using Lrp2 and Lrp7 as primers (Table 1). Plasmids pAC101, pAC102, pAC103, pAC104, pAC105, and pAC106 were obtained by cloning 394-, 386-, 400-, 390-, 398-, and 390-bp DNA fragments into pGEMT-easy vectors, respectively.

These aetiological factors associated with childhood

dent

These aetiological factors associated with childhood

dental caries need to be investigated further in longitudinal clinical trials. “
“The aim of this retrospective study was to quantify the level of dental developmental delay in a group of patients with Aperts syndrome when compared to matched controls. Twenty-six Dental Panoramic Tomographic (DPT) radiographs of patients with Apert syndrome attending Great Ormond Street Hospital were compared to controls (n = 29) from the Eastman Dental Hospital, UK. Dental development was assessed using the staging systems of Demirjian and Haavikko, and dental age (DA) was estimated using the weighted averages method. Dental age, as estimated using the 12 stages of Haavikko and eight stages of Demirjian, suggested no statistical evidence of developmental delay between the Aperts and control group. The hypothesis Palbociclib research buy ‘that there is no difference in the dental development of subjects with Apert syndrome, when compared to a group of matched controls’, was accepted. “
“The Children’s Fear Survey Schedule-Dental Subscale (CFSS-DS)

is a commonly used questionnaire that measures children’s dental fears. This study aimed to examine MDV3100 datasheet the reliability and validity of the Chinese version of the CFSS-DS. The CFSS-DS was translated into Chinese and administered to children in a dental office. The sample comprised 206 child patients aged 6–10 years, 42 of whom were selected for test–retest analysis. The behaviors of all

206 children were rated during their dental appointments and compared to their questionnaire results. The internal consistency (Cronbach’s α) was 0.85, and the test–retest reliability (intraclass correlation) was 0.71. The Chinese version of the CFSS-DS showed good criterion validity; children who were uncooperative on the Frankl Scale had higher mean CFSS-DS scores (Z = 5.79). Through factorization, three factors emerged: (1) dental treatment, (2) hospital personnel, and (3) invasive dental procedures. Girls reported more fear than boys (21.79 vs 19.91), and children who had painful C-X-C chemokine receptor type 7 (CXCR-7) dental experiences reported more fear (30.87 vs 20.00). These results suggest that the CFSS-DS is reliable and valid and operates in China as it does in other cultures. Further studies should include school samples to evaluate children who may not go to the dentist. “
“International Journal of Paediatric Dentistry 2013; 23: 173–179 Background:  Studies on the prevalence of enamel defects in the primary dentition as a whole are scarce, as most investigations examine specific population groups. Objectives:  The aim of this study was to evaluate the prevalence of enamel defects in primary teeth and determine whether prematurity, birthweight, and socio-demographic variables are associated with such defects. Design:  A cross-sectional study was carried out with 381 children aged 3–5 years.

For reason of clarity, we limited our analysis to genes induced ≥

For reason of clarity, we limited our analysis to genes induced ≥threefold and repressed ≥fivefold by rhamnolipids. Genes controlled by the same regulator form discrete clusters based on their expression pattern under different stress conditions (Fig. 2a). Genes belonging to the cell envelope stress response of B. subtilis are grouped in three clusters and can be assigned to two regulators, σM and the LiaRS TCS (Fig. 2b).

They are induced by cell wall antibiotics and rhamnolipids, but not by secretion stress (with the exception of liaH). One of these three clusters contains the target operon of the LiaRS TCS as well as the downstream genes gerAAAB. The other two clusters include mostly target genes of σM. Noteworthy, within the σM regulon, there is a subset of genes, including the mreBCDminCD operon involved in cell division, that is not induced by vancomycin (upper part of σM1 cluster in Fig. 2b). Differences in the induction BMS-354825 manufacturer profiles of subsets of σM-dependent

genes have been observed previously (Eiamphungporn & Helmann, 2008). Genes mediating the secretion stress response also cluster together (Fig. 2b). The CssRS-dependent target genes htrA and htrB are selleck chemical not only induced by secretion stress and rhamnolipids, but also weakly by vancomycin and bacitracin. Genes repressed by rhamnolipids show almost unchanged expression under the other conditions tested (Fig. 2c). One exception is the pyr operon, which is strongly repressed by rhamnolipids,

but weakly induced by friulimicin and vancomycin. Taken together, the hierarchical clustering analysis indicates that rhamnolipids induce a combination of two different stress responses: the cell envelope stress response represented by the LiaRS TCS and the ECF σ factor σM, and the heat and secretion stress response mediated by CssRS. Simultaneous induction of the LiaRS TCS and σM is common for cell wall antibiotics such as daptomycin, vancomycin, or bacitracin (Mascher et al., 2003; Hachmann et al., 2009; Wecke et al., 2009). But none of the σM-dependent target genes is induced by secretion stress, while both the CssRS and LiaRS TCS are induced by cell wall antibiotics, rhamnolipids, and secretion stress, but with different intensities stiripentol (Fig. 2d). Bacteria use signal transducing systems to detect harmful compounds and alter gene expression to protect the cell. We hypothesize that the signal transducing systems activated by rhamnolipids confer resistance and counteract cell damage caused by this antimicrobial compound. Therefore, we compared the growth behavior of B. subtilis wild-type cultures exposed to different rhamnolipid concentrations with strains carrying gene deletions leading to ‘ON’ or ‘OFF’ states of the induced signal transducing systems, which results either in no or constitutively high expression of the corresponding target genes.

7) and cyclin A (data not shown) could indicate the activation of

7) and cyclin A (data not shown) could indicate the activation of the wound-healing pathway against drug-induced damage. However, it is more likely that the changed expression learn more patterns of PCNA and cyclin A indicate that exposure to ZDV induces a loss of cell cycle control, which could play a role in the development of oral complications in HIV-infected patients under treatment with this drug. Decreased cytokeratin 6 expression supports this possibility. Effects of ZDV were seen on established tissue as early as 48 h after exposure to the drug. Therefore, we performed an experiment in which 0.5,

1 and 2 μg/mL ZDV was added to the day 8 raft cultures for 6, 12 or 24 h in order to examine the effects of short-term treatment on gingival tissue (Fig. 1). Immunohistochemical staining was then performed as in the previous experiments. Effects similar to those seen in previous experiments were seen at all concentrations and at all time-points. Even as early as 6 h and at the lowest concentration of ZDV, haematoxylin and eosin Quizartinib research buy staining and immunohistochemistry revealed that the drug changed both the morphology and the differentiation and proliferation status of tissues. Haematoxylin and eosin staining at the Cmax of ZDV showed that keratin pearls became more visible in treated tissue. Nuclei became more evident in the upper layers of the tissue and vaculation was reduced in tissues treated for 6, 12 and 24 h (Fig. 8, panels A–D). Similar

to tissue treated with ZDV for longer periods of time, tissue treated with the drug for 6, 12 and 24 h showed a decrease in cytokeratin 5 and involucrin expression at all drug concentrations (Fig. 8, panels E–L and data not shown). When ZDV was added to tissues at the 6-, 12- and 24-h time-points, a marked increase in cytokeratin 10 was seen in tissues at all drug concentrations (Fig. 8, panels M–P and data not shown). This was different from observations when ZDV was added for longer periods of time. Tissues treated at day 8 and harvested 2 and 4 days post treatment did

not sustain this increase in cytokeratin expression. Expression of cytokeratin 6, which is involved in wound healing, was decreased in tissues treated with ZDV for 6, 12 and 24 h at all drug concentrations tested (Fig. 8, panels Vitamin B12 Q–T). Like tissues treated for longer periods of time, an increase in PCNA was seen in tissues after 6, 12 and 24 h of ZDV exposure. PCNA expression also became evident in upper layers of tissue (Fig. 8, panels U–X and data not shown). Effects similar to those seen in previous experiments were seen at all concentrations and at all time-points. The effects were strongest at the 2 μg/mL concentration (Cmax) (Fig. 6). These results suggest that ZDV is able to mediate its effects through fast-acting pathways. HIV-positive patients taking HAART have reported many oral complications, which have a major impact on their overall health and quality of life.